Efficacy of cefiderocol, a novel siderophore cephalosporin, against multi-drug resistant Acinetobacter baumannii clinical isolates in Japan

In conclusion, this study showed that susceptibility to cefiderocol of MDRAB clinical isolates in Japan was equivalent to that of colistin or tigecycline. Cefiderocol could be a possible choice for the treatment of MDRAB infections.PMID:38296540 | DOI:10.7883/yoken.JJID.2023.364

Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Yoshitaka Kimura Nami Hatayama Yoshinori Sato Satoshi Nishida Yusuke Yoshino Source Type: research